Volume 3, Issue 5
Editorialp. 413
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Author(s): Tracey A Day, Cecilia A Morgan, James G Kublin
Editorialp. 417
Core outcomes in vitiligo trials: progress and challenges
Author(s): V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorialp. 421
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Author(s): Yoshihiro Oka
News and Viewsp. 425
Dual treatment approach may be the key to combating glioblastoma multiforme
Research Updatep. 433
The Scottish Childrens Research Network: challenges, opportunities and achievements
Author(s): Peter J Helms, Pamela Dicks
Research Updatep. 441
Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network
Author(s): Peter J Connelly, Emma Law, John M Starr
Commentaryp. 447
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Author(s): Charles H Hennekens, David J Bjorkman
Clinical Trail Prospectivep. 451
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Author(s): Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Review: Clinical Trail Outcomesp. 467
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Author(s): Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomesp. 479
New strategies for the treatment of inflammatory bowel diseases
Author(s): Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomesp. 493
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Author(s): Ariane Klein, Gerd Horneff
Acknowledgementsp. 505
